Health and health care; personal characteristics, 2014-2021
| Characteristics persons | Margins | Periods | Medication, last 14 days Persons with prescribed medicines (%) | Medication, last 14 days Persons with non-prescribed medicines (%) |
|---|---|---|---|---|
| Total | Value | 2014 | 40.2 | 38.7 |
| Total | Value | 2015 | 41.2 | 37.6 |
| Total | Value | 2016 | 40.4 | 38.4 |
| Total | Value | 2017 | 40.6 | 40.2 |
| Total | Value | 2018 | 40.9 | 40.1 |
| Total | Value | 2019 | 40.8 | 40.4 |
| Total | Value | 2020 | 39.4 | 39.8 |
| Total | Value | 2021 | 39.0 | 42.0 |
| Total | Lower bound 95% confidence interval | 2014 | 39.2 | 37.7 |
| Total | Lower bound 95% confidence interval | 2015 | 40.2 | 36.6 |
| Total | Lower bound 95% confidence interval | 2016 | 39.4 | 37.4 |
| Total | Lower bound 95% confidence interval | 2017 | 39.6 | 39.3 |
| Total | Lower bound 95% confidence interval | 2018 | 39.9 | 39.2 |
| Total | Lower bound 95% confidence interval | 2019 | 39.8 | 39.4 |
| Total | Lower bound 95% confidence interval | 2020 | 38.4 | 38.8 |
| Total | Lower bound 95% confidence interval | 2021 | 37.9 | 40.8 |
| Total | Upper bound 95% confidence interval | 2014 | 41.2 | 39.6 |
| Total | Upper bound 95% confidence interval | 2015 | 42.2 | 38.6 |
| Total | Upper bound 95% confidence interval | 2016 | 41.4 | 39.4 |
| Total | Upper bound 95% confidence interval | 2017 | 41.6 | 41.2 |
| Total | Upper bound 95% confidence interval | 2018 | 41.9 | 41.1 |
| Total | Upper bound 95% confidence interval | 2019 | 41.8 | 41.4 |
| Total | Upper bound 95% confidence interval | 2020 | 40.4 | 40.9 |
| Total | Upper bound 95% confidence interval | 2021 | 40.1 | 43.1 |
| Sex: Male | Value | 2014 | 37.3 | 32.1 |
| Sex: Male | Value | 2015 | 37.9 | 30.9 |
| Sex: Male | Value | 2016 | 37.0 | 32.6 |
| Sex: Male | Value | 2017 | 38.5 | 33.5 |
| Sex: Male | Value | 2018 | 37.7 | 33.8 |
| Sex: Male | Value | 2019 | 38.6 | 33.8 |
| Sex: Male | Value | 2020 | 37.2 | 33.1 |
| Sex: Male | Value | 2021 | 36.7 | 34.8 |
| Sex: Male | Lower bound 95% confidence interval | 2014 | 35.9 | 30.8 |
| Sex: Male | Lower bound 95% confidence interval | 2015 | 36.5 | 29.6 |
| Sex: Male | Lower bound 95% confidence interval | 2016 | 35.6 | 31.2 |
| Sex: Male | Lower bound 95% confidence interval | 2017 | 37.2 | 32.2 |
| Sex: Male | Lower bound 95% confidence interval | 2018 | 36.3 | 32.5 |
| Sex: Male | Lower bound 95% confidence interval | 2019 | 37.3 | 32.5 |
| Sex: Male | Lower bound 95% confidence interval | 2020 | 35.8 | 31.7 |
| Sex: Male | Lower bound 95% confidence interval | 2021 | 35.2 | 33.2 |
| Sex: Male | Upper bound 95% confidence interval | 2014 | 38.7 | 33.4 |
| Sex: Male | Upper bound 95% confidence interval | 2015 | 39.2 | 32.2 |
| Sex: Male | Upper bound 95% confidence interval | 2016 | 38.4 | 34.0 |
| Sex: Male | Upper bound 95% confidence interval | 2017 | 39.9 | 34.9 |
| Sex: Male | Upper bound 95% confidence interval | 2018 | 39.0 | 35.1 |
| Sex: Male | Upper bound 95% confidence interval | 2019 | 40.0 | 35.1 |
| Sex: Male | Upper bound 95% confidence interval | 2020 | 38.7 | 34.5 |
| Sex: Male | Upper bound 95% confidence interval | 2021 | 38.2 | 36.3 |
| Sex: Female | Value | 2014 | 43.1 | 45.1 |
| Sex: Female | Value | 2015 | 44.5 | 44.2 |
| Sex: Female | Value | 2016 | 43.7 | 44.1 |
| Sex: Female | Value | 2017 | 42.6 | 46.8 |
| Sex: Female | Value | 2018 | 44.1 | 46.4 |
| Sex: Female | Value | 2019 | 43.0 | 46.9 |
| Sex: Female | Value | 2020 | 41.6 | 46.5 |
| Sex: Female | Value | 2021 | 41.4 | 49.1 |
| Sex: Female | Lower bound 95% confidence interval | 2014 | 41.7 | 43.7 |
| Sex: Female | Lower bound 95% confidence interval | 2015 | 43.1 | 42.8 |
| Sex: Female | Lower bound 95% confidence interval | 2016 | 42.3 | 42.6 |
| Sex: Female | Lower bound 95% confidence interval | 2017 | 41.2 | 45.4 |
| Sex: Female | Lower bound 95% confidence interval | 2018 | 42.7 | 45.0 |
| Sex: Female | Lower bound 95% confidence interval | 2019 | 41.6 | 45.5 |
| Sex: Female | Lower bound 95% confidence interval | 2020 | 40.1 | 45.0 |
| Sex: Female | Lower bound 95% confidence interval | 2021 | 39.8 | 47.5 |
| Sex: Female | Upper bound 95% confidence interval | 2014 | 44.5 | 46.5 |
| Sex: Female | Upper bound 95% confidence interval | 2015 | 45.9 | 45.6 |
| Sex: Female | Upper bound 95% confidence interval | 2016 | 45.1 | 45.5 |
| Sex: Female | Upper bound 95% confidence interval | 2017 | 44.0 | 48.2 |
| Sex: Female | Upper bound 95% confidence interval | 2018 | 45.5 | 47.8 |
| Sex: Female | Upper bound 95% confidence interval | 2019 | 44.4 | 48.3 |
| Sex: Female | Upper bound 95% confidence interval | 2020 | 43.0 | 48.0 |
| Sex: Female | Upper bound 95% confidence interval | 2021 | 43.0 | 50.7 |
| Age: 0 to 3 years | Value | 2014 | 14.0 | 46.6 |
| Age: 0 to 3 years | Value | 2015 | 11.9 | 42.7 |
| Age: 0 to 3 years | Value | 2016 | 13.8 | 46.3 |
| Age: 0 to 3 years | Value | 2017 | 16.6 | 43.9 |
| Age: 0 to 3 years | Value | 2018 | 10.4 | 40.5 |
| Age: 0 to 3 years | Value | 2019 | 16.3 | 42.2 |
| Age: 0 to 3 years | Value | 2020 | 13.9 | 38.0 |
| Age: 0 to 3 years | Value | 2021 | 8.8 | 37.2 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2014 | 10.6 | 41.7 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2015 | 8.7 | 37.8 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2016 | 10.3 | 41.3 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2017 | 13.0 | 39.0 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2018 | 7.4 | 35.7 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2019 | 12.6 | 37.3 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2020 | 10.2 | 32.9 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2021 | 6.2 | 32.0 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2014 | 17.3 | 51.4 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2015 | 15.1 | 47.6 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2016 | 17.2 | 51.4 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2017 | 20.3 | 48.7 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2018 | 13.4 | 45.2 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2019 | 19.9 | 47.1 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2020 | 17.5 | 43.1 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2021 | 12.4 | 42.8 |
| Age: 4 to 11 years | Value | 2014 | 12.6 | 28.6 |
| Age: 4 to 11 years | Value | 2015 | 14.2 | 28.4 |
| Age: 4 to 11 years | Value | 2016 | 14.2 | 29.0 |
| Age: 4 to 11 years | Value | 2017 | 14.5 | 33.8 |
| Source: CBS. | ||||
Table explanation
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population in private households. These data can be grouped by several personal characteristics.
Data available for 2014-2021
Status of the data: final.
Changes as of July 31, 2023:
None, the table has been discontinued.
When will new data be published?
Not applicable. This table has been replaced, see paragraph 3 for a link to the new table.
Description topics
- Medication, last 14 days
- These questions deal with the use of medicine and the use of herbal medicines or vitamins, whether or not prescribed by a physician. The questions are posed to respondents of all ages.
- Persons with prescribed medicines
- Percentage of persons who in 14 days preceding the inquiry date used medicines prescribed by a physician. The contraceptive pill is not taken into consideration here.
- Persons with non-prescribed medicines
- Percentage of persons who in 14 days preceding the interview used (herbal) medicines or vitamins that were not prescribed by a physician.